BLAST CRISIS IN MYELOGENOUS LEUKAEMIA

This adverse event was reported 1234 times

These drugs are most commonly taken by patients reporting BLAST CRISIS IN MYELOGENOUS LEUKAEMIA:

# Drug Count
0 NILOTINIB 256
1 IMATINIB 248
2 IMATINIB MESYLATE 183
3 DASATINIB 148
4 HYDROXYUREA 74
5 PONATINIB HYDROCHLORIDE 72
6 CYTARABINE 42
7 ALLOPURINOL 41
8 BOSUTINIB 38
9 ASCIMINIB 34
See all common drugs associated with BLAST CRISIS IN MYELOGENOUS LEUKAEMIA

BLAST CRISIS IN MYELOGENOUS LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DASATINIB 148 0.0159
1 PONATINIB HYDROCHLORIDE 72 0.0137
2 ASCIMINIB 34 0.0097
3 NILOTINIB 256 0.0087
4 IMATINIB MESYLATE 183 0.0066
5 BOSUTINIB 38 0.0042
6 HYDROXYUREA 74 0.0035
7 VANCOMYCIN HYDROCHLORIDE 12 0.0014
8 MITOXANTRONE HYDROCHLORIDE 9 0.0014
9 AMINOCAPROIC ACID 1 0.0012
See all drugs enriched for association with BLAST CRISIS IN MYELOGENOUS LEUKAEMIA